非侵入性交付疫苗市场规模，份额，增长和行业分析，按类型（口服疫苗和鼻喷雾疫苗），按应用（公共和私人）以及2033年的区域预测
地区： 全球的 | 格式： PDF | 报告编号： PMI2020 | SKU 编号： 26418220 | 页数： 142 | 发布日期 : April, 2024 | 基准年份： 2024 | 历史数据： 2020 - 2023
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of非侵入性输送疫苗
1.2关键市场细分
1.2.1按类型进行非侵入性输送疫苗段
1.2.2
1.2.2通过应用程序
1.3信息学和信息来源
1.3.1 1.3.1研究方法论
1.3.2研究方法
1.3.2 1.3.2 1.3.3 Market base base base base base base base base base base base base
base base base base
base
base
1.3.4假设和注意事项
2 2 2.1全球市场概述
2.1.1 2.1.1全球非侵入性交付疫苗市场规模（M USD）估计和预测（2019-2031）
2.1.2 2.1.2全球非侵入性销售疫苗销售估计和市场范围2.2 19-21-201-21-201-21-221-221-201-2031（2019-20）摘要
2.3全球市场规模按地区划分
3无创疫苗市场竞争竞争格局竞争格局
3.1制造商的全球非侵入性交付疫苗销售（2019-2024）
3.2 3.2全球非侵入性疫苗疫苗的收入市场份额（由制造商造成的交付量）和第3层）
3.4制造商的全球无创疫苗平均价格（2019-2024）
3.5制造商非侵入性输送疫苗销售地点，服务面积，产品类型
3.6非侵入性疫苗疫苗的市场竞争状况和趋势
3.6.6.6.6.6.1 nor Inver vall> 3.6.1 nor vlobal valise valcine special Markets Markets Markets Markets Markets Marketation lar.6 3.6 3.6 3.6 3.6 3.6 3.6。 Noninvasive Delivery Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Noninvasive Delivery Vaccine Industry Chain Analysis
4.1 Noninvasive Delivery Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Noninvasive Delivery Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Noninvasive Delivery Vaccine Market Segmentation by Type
6.1细分市场开发潜力（类型）的评估矩阵
6.2按类型（2019-2024）按类型（2019-2024）按类型（2019-2024）按类型（2019-2024）按类型（2019-2024）按类型（2019-2024）按类型（2019-2024）按类型（2019-2024）
全球无侵袭性疫苗划分的全球无效疫苗（2019-20-20-20-20-20-2024）
7的全球无创疫苗销售市场份额
6.3全球无创疫苗的市场规模（2019-2024）
7.4应用程序
7.1段市场发展潜力的评估矩阵
7.2全球非侵入性交付疫苗市场按应用划分（2019-2024）
7.3全球非侵入性疫苗市场规模（M USD（M USD），应用程序（2019-2024）
7.4全球非影响力销售速度增长率8.4非侵入式销售率8.4 Vaccine Market Segmentation by Region
8.1 Global Noninvasive Delivery Vaccine Sales by Region
8.1.1 Global Noninvasive Delivery Vaccine Sales by Region
8.1.2 Global Noninvasive Delivery Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Noninvasive Delivery Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4墨西哥
8.3欧洲
8.3.1欧洲非侵入性输送疫苗销售按国家 /地区
8.3.2德国
8.3.3法国
8.3.4英国
英国
8.3.5 Italy
italy
8.3.6俄罗斯
8.4 8.4 Asias Pacific
Asia Asia ausia ausia ausia ausia dy 8.4.1 Asia Pacific nocia sales sales by Brobr by Brybr> 8.2.2.2.2.2 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Noninvasive Delivery Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Noninvasive Delivery Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Noninvasive Delivery Vaccine Basic Information
9.1.2 Merck Noninvasive Delivery Vaccine Product Overview
9.1.3 Merck Noninvasive Delivery Vaccine Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Noninvasive Delivery Vaccine SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Noninvasive Delivery Vaccine Basic Information
9.2.2 GSK Noninvasive Delivery Vaccine Product Overview
9.2.3 GSK Noninvasive Delivery Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Noninvasive Delivery Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Noninvasive Delivery Vaccine Basic信息
9.3.2 SANOFI无创疫苗产品概述
9.3.3 sanofi无创递送疫苗产品市场性能
9.3.4 sanofi sanofi非侵入性交付疫苗SWOT分析
9.3.3.3.3.5.59.3.5 sanofi商业概述
9.3.6 sanofi
9.3.6 sanofi
9.4 lan
9.4.4 lan
9.4 n.4 n.4 lanhou
9.4 n.4 lanhou
9.4 n.4 n.4 lanhou
9.4.4.4.4.4.4.4.4.4.4 lanhou。 Institute Noninvasive Delivery Vaccine Basic Information
9.4.2 Lanzhou Institute Noninvasive Delivery Vaccine Product Overview
9.4.3 Lanzhou Institute Noninvasive Delivery Vaccine Product Market Performance
9.4.4 Lanzhou Institute Business Overview
9.4.5 Lanzhou Institute Recent Developments
9.5 Serum Institute
9.5.1 Serum Institute Noninvasive Delivery Vaccine Basic Information
9.5.2 Serum Institute Noninvasive Delivery Vaccine Product Overview
9.5.3 Serum Institute Noninvasive Delivery Vaccine Product Market Performance
9.5.4 Serum Institute Business Overview
9.5.5 Serum Institute Recent Developments
9.6 Valneva
9.6.1 Valneva Noninvasive Delivery Vaccine Basic Information
9.6.2 Valneva Noninvasive Delivery Vaccine Product Overview
9.6.3 Valneva Noninvasive Delivery Vaccine Product Market Performance
9.6.4 Valneva Business Overview
9.6.5 Valneva Recent Developments
9.7 Shanghai United Cell
9.7.1 Shanghai United Cell Noninvasive Delivery Vaccine Basic信息
9.7.2上海联合细胞非侵入性输送疫苗产品概述
9.7.3上海联合细胞无侵入性交付疫苗疫苗产品市场性能
9.7.4上海联合细胞商业商务概述 Vaccine Basic Information
9.8.2 Bibcol Noninvasive Delivery Vaccine Product Overview
9.8.3 Bibcol Noninvasive Delivery Vaccine Product Market Performance
9.8.4 Bibcol Business Overview
9.8.5 Bibcol Recent Developments
9.9 PaxVax
9.9.1 PaxVax Noninvasive Delivery Vaccine Basic信息
9.9.2 paxvax无创疫苗产品概述
9.9.3 paxvax无创送货疫苗产品市场性能
9.9.4 paxvax业务概述
9.9.9.9.9.5 paxvax Paxvax最近的最新进展
9.10 vabiotech
9.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.11 vabiotectic
VABIOTECH非侵入性输送疫苗产品概述
9.10.3 Vabiotech无创送货疫苗产品市场绩效
9.10.4 Vabiotech商业概述
9.10.5 Vabiotech最近的发展近期开发量 Biological Noninvasive Delivery Vaccine Product Overview
9.11.3 Tiantan Biological Noninvasive Delivery Vaccine Product Market Performance
9.11.4 Tiantan Biological Business Overview
9.11.5 Tiantan Biological Recent Developments
9.12 EuBiologics
9.12.1 EuBiologics Noninvasive Delivery Vaccine Basic Information
9.12.2 EuBiologics Noninvasive Delivery Vaccine Product Overview
9.12.3 EuBiologics Noninvasive Delivery Vaccine Product Market Performance
9.12.4 EuBiologics Business Overview
9.12.5 EuBiologics Recent Developments
9.13 Panacea Biotec Ltd
9.13.1 Panacea Biotec Ltd Noninvasive Delivery Vaccine基本信息
9.13.2 PANACEA BIOTEC LTD无创递送疫苗产品概述
9.13.3 Panacea Biotec Ltd无侵蚀疫苗产品市场性能市场性能
9.13.4 Panacea Biotec Ltd Biaotec Ltd商业概述
9.13.5 Panacea Biotect Libotect ltdd
9.14生物医生
9.14.1生物培养的非侵入性疫苗基本信息
9.14.2 Bio-Med非侵入性送货疫苗产品概述
9.14.3 Bio-MED非侵入性疫苗产品市场绩效 Bio-Pharmaceuticals
9.15.1 Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Basic Information
9.15.2 Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Product Overview
9.15.3 Halfkin Bio-Pharmaceuticals Noninvasive Delivery Vaccine Product Market Performance
9.15.4 Halfkin Bio-Pharmaceuticals Business Overview
9.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
9.16 AstraZeneca
9.16.1 AstraZeneca Noninvasive Delivery Vaccine Basic Information
9.16.2 AstraZeneca Noninvasive Delivery Vaccine Product Overview
9.16.3 AstraZeneca Noninvasive Delivery Vaccine Product Market Performance
9.16.4 AstraZeneca Business Overview
9.16.5 AstraZeneca Recent Developments
9.17 Cipla
9.17.1 Cipla Noninvasive Delivery Vaccine Basic Information
9.17.2 Cipla Noninvasive Delivery Vaccine Product Overview
9.17.3 Cipla Noninvasive Delivery Vaccine Product Market Performance
9.17.4 Cipla Business Overview
9.17.5 Cipla Recent Developments
9.18 BCHT
9.18.1 BCHT Noninvasive Delivery Vaccine Basic Information
9.18.2 BCHT Noninvasive Delivery Vaccine Product Overview
9.18.3 BCHT Noninvasive Delivery Vaccine Product Market Performance
9.18.4 BCHT Business Overview
9.18.5 BCHT Recent Developments
10 Noninvasive Delivery Vaccine Market Forecast by Region
10.1 Global Noninvasive Delivery Vaccine Market Size Forecast
10.2 Global Noninvasive Delivery Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Noninvasive Delivery Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Noninvasive Delivery Vaccine Market Size Forecast by Region
10.2.4 South America Noninvasive Delivery Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Noninvasive Delivery Vaccine by Country
11 Forecast Market by Type and by Application (2025-2031)
11.1 Global Noninvasive Delivery Vaccine Market Forecast by Type (2025-2031)
11.1.1 Global Forecasted Sales of Noninvasive Delivery Vaccine by Type (2025-2031)
11.1.2 Global Noninvasive Delivery Vaccine Market Size Forecast by Type (2025-2031)
11.1.3 Global按类型（2025-2031）按类型（2025-2031）进行的无创送货疫苗的预测价格
11.2全球非侵入性输送疫苗市场按应用（2025-2031）预测
11.2.1全球非侵入性疫苗销售（kilotons sales（kilotons a sales（kilotons））通过应用程序
11.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2 （2025-2031）
12结论和关键发现